Ministry of Health Dispels Misinformation on Medicine Price Surge from April 1

▴ Medicine Price Surge from April 1
Detailed pricing information, including the updated ceiling prices based on the WPI adjustment, is available on the NPPA website (www.nppaindia.nic.in)

In response to widespread reports claiming a surge in medicine prices effective from April 1, 2024, the Ministry of Health and Family Welfare has refuted these claims as false and misleading. The clarification emphasizes that the price adjustments are based on specific regulatory guidelines and are not indicative of across-the-board increases in medication costs.

Understanding Drug Price Control Orders (DPCO) 2013: The Ministry highlighted the framework of the Drug Price Control Orders (DPCO) 2013, which categorizes medications into scheduled and non-scheduled formulations. Scheduled formulations are essential medicines listed in Schedule I of the DPCO, subject to price regulation to ensure affordability and accessibility.

Annual Price Review and WPI Adjustment: The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, conducts an annual review of the ceiling prices for scheduled formulations using the Wholesale Price Index (WPI). The recent review, based on the WPI data for 2023, resulted in a marginal adjustment of (+) 0.00551% for scheduled medications.

Impact on Medication Prices: Contrary to reports suggesting significant price hikes, the Ministry clarified that most medication price caps remain unchanged, with only a minimal adjustment for a subset of medicines. Approximately 54 medications will see a negligible increase, ranging from ₹0.01 for medications priced between ₹90 and ₹261.

Ceiling Prices and Regulatory Oversight: The current ceiling pricing structure for 923 medications is designed to maintain affordability and prevent undue price fluctuations. Manufacturers are bound by regulatory guidelines to adhere to the prescribed price limits, ensuring that essential medications remain accessible to the general population.

Transparency and Information Access:Detailed pricing information, including the updated ceiling prices based on the WPI adjustment, is available on the NPPA website (www.nppaindia.nic.in). This transparency enables stakeholders, including healthcare providers and consumers, to access accurate pricing data and understand the regulatory framework governing medication costs.

Regulation of Non-Scheduled Formulations: For non-scheduled formulations, manufacturers have the flexibility to set prices, but they are subject to certain restrictions outlined in the DPCO 2013. Notably, any price increase for non-scheduled formulations is capped at 10% within a 12-month period, ensuring reasonable pricing practices.

Ensuring Affordability and Access to Essential Medications: The Ministry's statement showcases the government's commitment to maintaining affordability and accessibility of essential medications for all segments of society. The regulatory framework established under the DPCO 2013 aims to strike a balance between industry sustainability and public health priorities.

Upholding Price Stability in Medication Sector: The Ministry's clarification dispels misinformation surrounding medicine price increases, emphasizing the measured and transparent approach to regulating medication costs. By leveraging data-driven assessments and regulatory oversight, the government aims to safeguard the interests of patients and ensure continued access to essential healthcare interventions. The public is encouraged to refer to official sources for accurate information on medication pricing and regulatory updates.

Tags : #

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Maternal and Infant Health in Focus as India Observes World Health Day 2025April 05, 2025
Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025